An audit of surgical management of gastrointestinal stromal tumours (GIST)

被引:88
作者
Bucher, P
Egger, JF
Gervaz, P
Ris, F
Weintraub, D
Villiger, P
Buhler, LH
Morel, P
机构
[1] Univ Hosp Geneva, Dept Surg, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Visceral & Transplantat Surg Clin, CH-1211 Geneva 14, Switzerland
[3] Univ Hosp Geneva, Div Pathol, Geneva, Switzerland
[4] Univ Hosp Geneva, Lab Weintraub, Geneva, Switzerland
来源
EJSO | 2006年 / 32卷 / 03期
关键词
gastrointestinal stromal tumours (GIST); proto-oncogene protein c-kit/KIT/CD117; prognostic factors; outcomes; classification; imatinib mesylate; surgery; human; survival analysis;
D O I
10.1016/j.ejso.2005.11.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Aim: To analyze GIST outcome after primary resection and to determine if a new grading system could adequately predict there prognosis. Methods: A retrospective review (1993-2002) identified 80 patients who underwent primary surgical resection for, c-KIT positive, GIST. Follow-up was complete for all patients (median follow-up 42, range 1-132, months). GIST were classified as low or high grade according to the following parameters: size, mitotic rate, mitotic index (MiB1), presence of necrosis, invasion of adjacent structure and presence of metastasis. Results: GIST originated from the stomach (46), small bowel (30), colon and rectum two and mesentery two. At surgery, 94% of cases presented with localized disease and 6% blood born metastasis with or without lymph node invasion. Resections were complete (R0) in 72 cases. R0 resection correlated with prognosis(p < 0.01). Sixty GIST were classified as low grade (median follow-up 60 months) and 20 as high grade (median follow-Lip 27 months). Five-year actuarial survival of patients with low or high grade GIST were of 95 and 21%, respectively, (p < 0.001). Conclusion: Prognosis of GIST after surgical treatment is influenced by completeness of primary resection and tumour malignant potential. Low grade GIST have an excellent prognosis after surgery alone, while high grade GIST have a high rate of recurrence after primary resection. Adjuvant treatment should be advocated for patient with either high grade GIST or after incomplete primary resection. The presented grading system can reliably predict GIST outcome after primary surgical treatment. Complete surgical resection offers good chance of cure for low grade GIST, while for high grade GIST surgery alone is not sufficient. The presented grading system could be used to identify patients who may benefit of adjuvant treatment with imatinib mesylate after GIST resection. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 40 条
[1]
Prognostic factors after surgery of primary resectable gastrointestinal stroma tumours [J].
Aparicio, T ;
Boige, V ;
Sabourin, JC ;
Crenn, P ;
Ducreux, M ;
Le Cesne, A ;
Bonvalot, S .
EJSO, 2004, 30 (10) :1098-1103
[2]
Are there any prognostic factors for small intestinal stromal tumors? [J].
Bucher, P ;
Taylor, S ;
Villiger, P ;
Morel, P ;
Brundler, MA .
AMERICAN JOURNAL OF SURGERY, 2004, 187 (06) :761-766
[3]
Bucher P, 2004, SWISS MED WKLY, V134, P145
[4]
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib:: a centre-based study of 17 patients [J].
Bümming, P ;
Andersson, J ;
Meis-Kindblom, JM ;
Klingenstierna, H ;
Engström, K ;
Stierner, U ;
Wängberg, B ;
Jansson, S ;
Ahlman, H ;
Kindblom, LG ;
Nilsson, B .
BRITISH JOURNAL OF CANCER, 2003, 89 (03) :460-464
[5]
Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: A clinic comparison [J].
Clary, BM ;
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Brennan, MF .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (04) :290-299
[6]
Gastrointestinal stromal tumours [J].
Connolly, EM ;
Gaffney, E ;
Reynolds, JV .
BRITISH JOURNAL OF SURGERY, 2003, 90 (10) :1178-1186
[7]
CORLESS C, 2004, J CLIN ONCOL, V22, P318
[8]
The GIST of targeted cancer therapy:: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571) [J].
DeMatteo, RP .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (09) :831-839
[9]
Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[10]
Clinical management of gastrointestinal stromal tumors: Before and after STI-571 [J].
DeMatteo, RP ;
Heinrich, MC ;
El-Rifai, WM ;
Demetri, G .
HUMAN PATHOLOGY, 2002, 33 (05) :466-477